T-cell attacking cancer tumour


At GSK Oncology we are committed to improving outcomes for patients who are affected by cancer. Browse our dedicated therapy area sites below.

Our products

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or uksafety@gsk.com.

© 2021 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.

November 2022 | PM-GB-ON-WCNT-220001 (V1.0)